A (very) quick look back at the Google story over the last 11 years. From Stanford to Mountain View and around the world, featuring many different products, starting with BackRub (Search) up to Google Wave, StreetView and Chrome.

Complete your cholesterol care.
“I’ve been taking medication to lower my bad cholesterol but I needed more help to manage the other two parts.”
Good (HDL) / Bad (LDL) / Trigs
It’s time. Crestor

Learn more: www.trilipix.com or call 1.888.866.3073

Trilipix. Complete your cholesterol care

Fenofibrate is a drug of the fibrate class. Fenofibrate was discovered by Groupe Fournier SA, before it was acquired by Solvay Pharmaceutical in 2005. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing tryglycerides level. It also appears to have a beneficial effect on the insulin resistance featured by the metabolic syndrome.[1] It is used alone or in conjunction with statins in the treatment of hypercholesterolemia and hypertriglyceridemia. Fenofibrate is sold under the brand name Tricor by Abbott Labs, Lofibra by Teva, Lipanthyl by Solvay Pharmaceutical and Fenocor-67 by Ordain Health Care Pvt Ltd. – Wikipedia

2009

Today, I took steps to balance my type 2 diabetes.
Today, I chose salad and talked to my doctor.

It’s time. Crestor

Call 1-888-JANUVIA or visit Januvia.com

A different way. Januvia.

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only 2nd Generation DPP4 inhibitor currently available. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) is an alternative drug that also works with the incretin system. – Wikipedia

US News and World Report February 2009

The Wall Street Journal reports that Pfizer will air new Lipitor TV ads that feature a non-celebrity:

“The new television ad, set to debut Tuesday, features a testimonial from heart-attack survivor John Erlendson, a 58-year-old California talent agent. He didn’t take a cholesterol-fighting drug before his heart attack last year despite a history of high cholesterol, and his ad urges people in similar situations to be more proactive.” (See “Pfizer Drops Celebrity Pitch in New Lipitor Spots“).

According to the WSJ article, Erlendson will be paid “a union scale rate,” as opposed to $1.35 million that Pfizer paid Dr. Robert Jarvik for Lipitor ads that he famously appeared in (see “Jarvik: A Modern DTC Tragedy“).

What exactly is the Screen Actors Guild (SAG) “union scale rate” for TV commercials?

You can’t get that information the SAG Web site — you have to be a member and although I am producing my own video commercials, I am not a card-carrying SAG member.

Using Google, however, I easily found a document from an agent’s Web site that outlined the rates for 2006 (see here). For “on-camera principals,” the rate is $567.10 (not including an $83.93 pension contribution).

Doing the math, I find that Pfizer will save $1,349,432.90 using Erlendson vs. Jarvik! The actual savings might be less if you factor in the recent increase in SAG union rates won as a result of the recent strike.

Whatever! Pfizer is saving a bundle!

I have a question for Mr. Erlendson: Are you independently wealthy? Are you getting “residuals” in the form of free promotion for yourself and your talent agency?

After all, if Mr. Erlendson can land this gig with Pfizer, he must be a damn good talent agent!

Original post